Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00623818 · ClinicalTrials.gov registry record

Mirror Therapy for Phantom Limb Pain

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
45
Enrollment target

NCT00623818 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00623818 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

This study, conducted at the National Institutes of Health (NIH) and at Walter Reed Army Medical Center (WRAMC), will explore the phenomenon of phantom limb pain (a continued feeling of pain in an amputated limb) and will use functional magnetic resonance imaging (fMRI) to investigate the effect of mirror therapy on phantom limb pain. Right-handed people between 18 and 75 years of age who are in the WRAMC Military Amputee Research Program and healthy control subjects may be eligible for this study. Participants undergo the following procedures: Amputees * Questionnaires to assess strength of handedness and footedness and pain perception. * Mirror therapy for phantom limb pain five times a week for 4 weeks in 15-minute sessions. * MRI and fMRI scans before starting mirror therapy, after 2 weeks of therapy and after 4 weeks of therapy. MRI uses a magnetic field and radio waves to image brain tissue. The subject lies on a table that can slide in and out of the scanner (a metal cylinder). The structural MRI scan lasts about 30 minutes. For fMRI, the subject performs tasks while in the scanner in order to show changes in brain activity involved in performing those tasks. Subjects are shown pictures of feet and other body parts, are asked to move their feet, and receive tactile (touch) stimulation of the foot or other body parts. Control Subjects One group of control subjects undergoes a single fMRI procedure. A second group of control subjects undergoes the same sequence of three fMRIs over the same time period as the amputee subjects. None of the control subjects undergo mirror therapy. ...

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2008-03-05
Est. Completion 2019-12-10

What the Registry Record Tells You About NCT00623818

The ClinicalTrials.gov registry entry for NCT00623818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00623818 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00623818 about?

NCT00623818 is a clinical study titled "Mirror Therapy for Phantom Limb Pain". This study, conducted at the National Institutes of Health (NIH) and at Walter Reed Army Medical Center (WRAMC), will explore the phenomenon of phantom limb pain (a continued feeling of pain in an amputated limb) and will use functional magnetic resonance imaging (fMRI) to investigate the effect of ...

What is the current status of trial NCT00623818?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2008-03-05. Estimated completion is 2019-12-10.

Who is sponsoring clinical trial NCT00623818?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.